Advertisement

Topics

Rigel Pharmaceuticals, Inc. Company Profile

15:33 EST 23rd November 2017 | BioPortfolio


News Articles [482 Associated News Articles listed on BioPortfolio]

Rigel Pharma: FDA Says Not Planning Of ODAC Meeting To Discuss Fostamatinibs NDA

WASHINGTON (dpa-AFX) - Rigel Pharmaceuticals, Inc. (RIGL), a biotechnology company, announced Monday an update on U.S. Food and Drug Administration review of Fostamatinib for immune thrombocytopen...

Rigel to Present at Cantor Fitzgerald Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Sept. 19, 2017 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, is sche...

Investor Network: Rigel Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 7, 2017 / Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) will be discussing their earnings results in their Q3 Earnings Call to be held on November 7, 2017 at 5:00 ...

Rigel nets $65.5mm through follow-on public offering

Rigel Pharmaceuticals Inc. netted $65.5mm through the public sale of 20.8mm common shares (including the overallotment) at $3.35. The company is developing treatments for blood, immune, kidney, respir...

Rigel, Novartis to Collaborate on Five Drug Discovery Projects

Rigel Inc. (South San Francisco) and Novartis Pharma AG (Basel, Switzerland) will work together on five different five-year research projects to identify targets for products that can treat, prevent, ...

Rigel Pharma: Fostamatinib Meets Endpoint In Stage 1 Of AIHA Phase 2 Study

WASHINGTON (dpa-AFX) - Rigel Pharmaceuticals, Inc. (RIGL) announced the company recently completed enrollment of Stage 1 of its Phase 2, open-label, multi-center, two-stage study of its investigat...

Rigel Pharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 17102017] Prices from USD $350

Rigel Pharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Rigel Pharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Alliances an...

Rigel Pharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 15062017] Prices from USD $350

Rigel Pharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Rigel Pharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Alliances an...

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]

EYEWASH STATION ADDITIVE CONCENTRATE

PubMed Articles [121 Associated PubMed Articles listed on BioPortfolio]

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Comparative study on pharmaceuticals adsorption in reclaimed water desalination concentrate using biochar: Impact of salts and organic matter.

The synergistic impact of salts and organic matter on adsorption of ibuprofen and sulfamethoxazole by three types of biochar and an activated carbon was investigated using reclaimed water reverse osmo...

Effects of exposure to pharmaceuticals (diclofenac and carbamazepine) spiked sediments in the midge, Chironomus riparius (Diptera, Chironomidae).

Human and veterinary pharmaceuticals and degradation products are continuously introduced into the environment. To date, there is a lack of information about the effects of pharmaceuticals in spiked t...

Clinical Trials [207 Associated Clinical Trials listed on BioPortfolio]

Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies

The purpose of this new research study is to gain additional information about how safe and effective R935788 is over a longer period of time.

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Companies [1289 Associated Companies listed on BioPortfolio]

Rigel Pharmaceuticals

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases and cancer, as well as viral and metabolic disease...

Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc.

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

More Information about "Rigel Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Rigel Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Rigel Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Rigel Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Rigel Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Rigel Pharmaceuticals, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record